Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Testing effectiveness (Phase 2)Active Not RecruitingNCT04175912What this trial is testingTesting the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the LiverWho this might be right forMetastatic CholangiocarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+12 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT02042443What this trial is testingTrametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by SurgeryWho this might be right forAdult CholangiocarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage C Adult Hepatocellular Carcinoma+16 more National Cancer Institute (NCI) 53
Early research (Phase 1)Study completedNCT00397384What this trial is testingErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT00019474What this trial is testingCombination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract CancerWho this might be right forExtrahepatic Bile Duct CancerGastric CancerGastrointestinal Carcinoid Tumor+3 more Montefiore Medical Center 60
Early research (Phase 1)Study completedNCT00019513What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasWho this might be right forColorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Looking for participantsNCT07105748What this trial is testingHAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA)Who this might be right forMixed Hepatocellular-cholangiocarcinoma Fudan University 45
Testing effectiveness (Phase 2)Ended earlyNCT01229111What this trial is testingCediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary CancersWho this might be right forAdult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile Duct+8 more National Cancer Institute (NCI) 14
Not applicableLooking for participantsNCT06849180What this trial is testingNovel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal DataWho this might be right forCombined Hepatocellular-cholangiocarcinomaCombined Hepatocellular Carcinoma and CholangiocarcinomaCombined Hepatocellular and Cholangiocarcinoma Zhongda Hospital 198
Not applicableUnknownNCT05662488What this trial is testingFAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination TherapyWho this might be right forHepatocellular CarcinomaBile Duct Cancer Peking Union Medical College Hospital 25
Not applicableActive Not RecruitingNCT05064553What this trial is testingALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased RiskWho this might be right forHepatocellular CarcinomaHepatocellular CancerHepatitis B+2 more Exact Sciences Corporation 2,990
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06033118What this trial is testingGemox Combined With Anlotinib and Sintilimab in Advanced cHCC-ICCWho this might be right forCombined Hepatocellular Cholangiocarcinoma Sichuan University 25
Testing effectiveness (Phase 2)Looking for participantsNCT05223816What this trial is testingAn Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic CholangiocarcinomaWho this might be right forHepatocellular CarcinomaIntrahepatic Cholangiocarcinoma Virogin Biotech Canada Ltd 97
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT03230318What this trial is testingDerazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic CholangiocarcinomaWho this might be right forIntrahepatic CholangiocarcinomaCombined Hepatocellular and Cholangiocarcinoma Basilea Pharmaceutica 148
Early research (Phase 1)UnknownNCT05240690What this trial is testingUmbilical Cord Blood Derived MAK Immune Cells Combined With Standard Second-Line Treatments for Hepatobiliary and Pancreatic MalignanciesWho this might be right forStage IV Pancreatic CancerHepatocellular Carcinoma , Cholangiocarcinoma Zhou Fuxiang 27
Early research (Phase 1)Study completedNCT03829436What this trial is testingTPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced CancersWho this might be right forHepatocellular CarcinomaMetastatic Castration Resistant Prostate CancerRenal Cell Carcinoma+9 more Tempest Therapeutics 38
Early research (Phase 1)Study completedNCT00002854What this trial is testingHigh-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerWho this might be right forCancer City of Hope Medical Center 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243951What this trial is testingPhase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaWho this might be right forCombined Hepatocellular-cholangiocarcinomaLiver Neoplasms Shanghai Zhongshan Hospital 75
Testing effectiveness (Phase 2)Looking for participantsNCT05451043What this trial is testingDurvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)Who this might be right forPancreatic CancerHepatocellular CancerBiliary Tract Cancer+1 more AHS Cancer Control Alberta 62